Clinical trial
PRECISE: Preoperative Radiotherapy to Elicit Critical Immune Stimulating Effects
NCT03359954 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRECISE: Preoperative Radiotherapy to Elicit Critical Immune Stimulating Effects
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- November 16, 2017
- Completion date
- October 31, 2027
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
estrogen receptor positive, her2/neu negative, invasive breast carcinoma, progesterone receptor positive